María Angeles Lima - Concepedia

Author

María Angeles Lima

Also Known As

Lima, María Angeles, M A Lima, M Angeles Lima, M. Angeles Lima, M.A. Lima, M.A.A. Souza Lima, Maria Angeles Lima, María A. Rengifo de Lima, María Angeles Lima, Marıa Angeles Lima

Publications

948

Citations

H-Index

Concepts

All Affiliations

Médecins Sans Frontières Rajendra Memorial Research Institute of Medical Sciences Fundação Oswaldo Cruz Médecins Sans Frontières Universidade Federal de Mato Grosso do Sul

About

María Angeles Lima is an author at Médecins Sans Frontières specializing in parasitology, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	249
2	Public Health	4	4	221
3	Epidemiology	4	4	221
4	Global Health	3	3	199
5	Anatomy	1	1	28

María Angeles Lima

Publications

792

Citations

H-Index

Page 1

	Year	Citations
Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières Oliver Yun, María Angeles Lima, Tom Ellman, PLoS neglected tropical diseases	2009	183
Who Is a Typical Patient with Visceral Leishmaniasis? Characterizing the Demographic and Nutritional Profile of Patients in Brazil, East Africa, and South Asia Michael O. Harhay, Piero Olliaro, Michel Vaillant, American Journal of Tropical Medicine and Hygiene MalariaDrug-dosing RecommendationsEast AfricaPharmacotherapyVisceral Leishmaniasis	2011	73
Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, PLoS neglected tropical diseases	2014	66
Natural History of a Visceral Leishmaniasis Outbreak in Highland Ethiopia Mercè Herrero, Daniel Argaw, Abate Mulugeta, American Journal of Tropical Medicine and Hygiene Parasitic DiseaseMalariaDisease OutbreakVisceral LeishmaniasisVector-borne Pathogen	2009	66
Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, PLoS neglected tropical diseases	2014	65
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India Raman Mahajan, Pradeep Das, Petros Isaakidis, Clinical Infectious Diseases	2015	63
Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome) Sakib Burza, Raman Mahajan, Prabhat Kumar Sinha, PLoS neglected tropical diseases	2014	62
HIV and Visceral Leishmaniasis Coinfection in Bihar, India: An Underrecognized and Underdiagnosed Threat Against Elimination Sakib Burza, Raman Mahajan, Marta Sanz, Clinical Infectious Diseases Clinical Infectious DiseaseParasitic ProtozoaNeurovirologyGlobal HealthClinical Epidemiology	2014	60
Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India Prabhat Kumar Sinha, Paul Roddy, Pedro Pablo Palma, American Journal of Tropical Medicine and Hygiene	2010	43
Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, PLoS neglected tropical diseases	2014	40

Page 1